Acumen Pharmaceuticals, Inc.
SEC Document
SEC Filing
On June 6, 2023, Acumen Pharmaceuticals, Inc. (the “Company”) held its 2023 annual meeting of stockholders (the “Annual Meeting”). As described in Item 5.07 below, the Company’s stockholders approved the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation” and, as amended, the “Amended Certificate of Incorporation”) to reflect Delaware law provisions allowing for the exculpation of officers.